Actions aim to lower patient out-of-pocket costs Expands transparency for both patients and those who provide their benefits "We know that health care and prescription drugs need to be more affordable ...

There have been several recent efforts to crack down on pharmacy benefit managers, from bills in Congress to an investigation by the Federal Trade Commission. But the state of Arkansas has been the ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and ...

The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...

April 3 (Reuters) - Pharmacy benefit managers OptumRx and Express Scripts have asked the federal judge overseeing nationwide litigation over the opioid crisis to recuse himself from cases against them ...